Kalle Känd

MS Pharma - CEO of MS Pharma

Profile

Kalle Känd has been the Chief Executive Officer (CEO) of MS Pharma since February 2020.
Before joining MS Pharma, Kalle held the CEO position at Acino International AG, Switzerland, from 2016-2018. He was the company’s Chief Commercial Officer (CCO) from 2014-2016.

Throughout his career, Kalle has held various commercial and strategy positions like VP Strategy Emerging Markets for Takeda, Regional Head of Strategy and Alliance Management
for Nycomed Russia/CIS,
and Director International Marketing for Nycomed.

Kalle has more than 20 years of experience in the international pharmaceutical industry, closed several M&A and licensing deals, divestments, and carve-outs. Kalle has a proven track record of leading companies, and sales & marketing organizations in multiple geographical regions.

Kalle Känd studied medicine at Tartu and Helsinki University and received a Doctor of Medicine degree.

Firm Profile
Founded in 1989, MS Pharma has more than 2000 employees located across the MENA region.

MS Pharma is a multinational pharmaceutical company specializing in the development, production, and distribution of generic and specialty medicines.

MS Pharma markets a wide range of generic and biotech products and is active in several therapeutic areas, including cardiovascular, CNS, respiratory, and oncology. Dosage forms include solids, liquids, cytotoxic drugs, and sterile injectables.

MS Pharma has manufacturing facilities in four countries in the META region and an established track record of manufacturing across a wide range of dosage forms. All our manufacturing sites are GMP accredited.

At MS Pharma, our first responsibility is towards patients. The quality of our products is paramount, and all our manufacturing sites have dedicated Quality units.

Quality Management runs through our entire value chain, from supplier inspections to raw materials, production, and marketing. Before placing a product on the market, each batch of the final product is tested again. And finally, we continue testing our products during the shelf life up to the expiry date.
By controlling all steps in the process, we commit to providing high-quality products to the communities we serve.

Why Partner with us?
Our aim at MS Pharma is to be a trusted partner for pharmaceutical companies looking to expand their geographical footprint in the MENA region.

By choosing MS Pharma as a partner, you gain access to our strong market access, regulatory, and sales & marketing network and our excellent track record to bring products successfully to market in the region.

We are seeking to expand our product portfolio rapidly. Our business development activities are focused on prescription products, branded and generic, that meet international quality standards. We are particularly interested in innovative products, biosimilars, and complex generics.

We will consider in-licensing, acquisition, (co-)promotion, revenue-sharing, and other partnering opportunities.

We also offer our partners access to our production network in Algeria, Jordan, and Saudi Arabia as a contract manufacturing option, to increase local market access and operational flexibility.